
|Videos|July 17, 2020
Glaucoma 360: Drug delivery contact lens technology
Author(s)Alex Delaney-Gesing
ICYMI: Chris Adams, CEO of Diopter Corp, discusses the company's drug delivery contact lens technology in the pipeline that works to treat ocular surface disease, during the 2020 Glaucoma 360 meeting in San Francisco, California.
Advertisement
ICYMI: Chris Adams, CEO of Diopter Corp, discusses the company's drug delivery contact lens technology in the pipeline that works to treat ocular surface diseases, during the 2020 Glaucoma 360 meeting in San Francisco, California.
Advertisement
Latest CME
Advertisement
Advertisement
























